Small Molecule API CMO Partners

The FDA defines Active Pharmaceutical Ingredient (API) as any substance or mixture of substances intended to be used as the active ingredient in the manufacture of a drug or medicinal product.

Your API may need to be in the form of liquids, powders, crystals and extracts, and processed by chemical synthesis, plant extraction, or other means. The synthesis of small-molecule APIs, although successfully performed for decades, still presents a complicated, multi-step process involving chemical transformations and operations on a range of raw materials with different physical and chemical properties. Specialized expertise is needed to achieve success, from small-scale development, to cGMP clinical and commercial quantities.

How can we help?

Looking for help with your Small Molecule API project? If you're searching for information or a supplier, let Life Science Connect lend you a hand.

Submit A Question

Small Molecule API CMOs

Small Molecule API CMO - Abbvie
Abbvie

AbbVie Contract Manufacturing partners with companies across the globe to develop, scale and manufacture pharmaceutical products and bring them successfully to market. Drawing on more than four decades of success as the manufacturing division of AbbVie, we have the depth of experience and the technical knowledge to navigate issues and deliver the innovative solutions customers need. We are much more than a CMO – we are your partner for success.

Capabilities

 

Small Molecule API CMO - Asymchem
Asymchem

Asymchem is a leading global CDMO established in 1995 in North Carolina, U.S., dedicated to delivering integrated, end-to-end solutions across the pharmaceutical value chain. Operating from a global network of R&D and manufacturing facilities in China, the U.S and UK, Asymchem employs more than 9,000 professionals worldwide, with 45% of those dedicated to R&D.

Capabilities

 

Small Molecule API CMO - Catalent
Catalent

Catalent is a global leader in providing integrated services, superior drug delivery technologies and manufacturing solutions to help life science innovators develop and launch successful pharmaceuticals, biologics and consumer health products.


Have questions about selecting the right CMO?

The Life Science Connect team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


Small Molecule API CMO - Curia
Curia

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites, and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities.

Small Molecule API CMO - Grace Fine Chemical Manufacturing Services
Grace Fine Chemical Manufacturing Services

Grace’s Fine Chemical Manufacturing Services (FCMS) is a North American contract development and manufacturing organization (CDMO) with decades of experience partnering with biotechs and pharma companies to solve complex chemistry challenges and seamlessly scale your small molecule project, from early development through commercial manufacturing and every phase in between. We offer development and manufacturing support for RSMs, intermediates, peptide building blocks, and custom active pharmaceutical ingredients (APIs) at our integrated U.S.-based facilities.

Capabilities

Small Molecule API CMO - Lonza
Lonza

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. Our unparalleled breadth of offerings enables our customers to commercialize their discoveries and innovations in the healthcare industry.


Small Molecule API CMO - MilliporeSigma
MilliporeSigma

With decades of expertise, we deliver preclinical to commercial success for your small molecule API program through a consultative and phase appropriate approach. With Millipore® CTDMO Services, tap into our global network to seamlessly execute your custom API projects. From conception to commercialization, we tackle the toughest small molecule API synthesis challenges from grams to commercial quantities.

Capabilities

Small Molecule API CMO - Nanoform
Nanoform

Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners to improve the lives of patients globally by overcoming drug development and delivery challenges through its game-changing nanoforming technologies, novel formulation capabilities and GMP manufacturing facilities. The company’s dedicated, multi-disciplinary team has a combined experience of launching 100+ medicines.

Capabilities

Small Molecule API CMO - PCI Pharma Services
PCI Pharma Services

PCI Pharma Services is an integrated full service provider, a proven and trusted partner to leading companies in the global healthcare industry. We offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to successful commercialization, delivering speed-to-market and commercial success for our customers.

Capabilities


Small Molecule API CMO - Pfizer
Pfizer CentreOne

Pfizer CentreOne is a global CDMO embedded within Pfizer and a leading supplier of specialty APIs.

Working together with our customers, we combine our knowledge with open dialogue to solve challenges.

Small Molecule API CMO - Pharma Expanse
Pharma Expanse

Pharma Expanse is a leading provider of contract development and manufacturing services, supporting manufacturing of RSMs, APIs, Drug Product, and Cell Therapies. Pharma Expanse has drug product capabilities across a number of modalities including small molecules, biologics, ADCs, peptides, and nucleic acids (mRNA). Cell Therapy capabilities include cell line development, master cell banking, and GMP manufacturing of allogeneic induced Pluripotent Stem Cells (iPSCs) for oncology and regenerative medicine.

The Pharma Expanse network currently spans across 20 manufacturing sites in 8 countries and can support discovery, preclinical, clinical, and commercial programs for New Chemical Entities (NCEs).

Small Molecule API CMO - SK pharmteco
SK pharmteco

SK pharmteco’s mission is to build strong partnerships that deliver life-saving therapies and improve patient outcomes. With seven global facilities, we support the entire product lifecycle, from development to commercial manufacturing, with a collaborative “One Team” approach focused on transparency and trust. Offering CDMO services for small molecules, cell and gene therapy, and analytical testing—connect with our experts today!

Capabilities


Small Molecule API CMO - X-Chem
X-Chem

X-Chem is redefining small molecule drug discovery through a powerful combination of computational sciences, discovery chemistry and data-driven insight. As the pioneer and global leader in DNA-encoded library (DEL) technology, X-Chem provides the foundation for smarter hit identification, accelerated lead progression and greater confidence in early discovery.

Capabilities